CD19 and Miyoshi myopathy: Currently, there is little information on this approach; however, Jackson et al. reported a retrospective analysis of HLA antibodies in HS patients receiving CAR-T (CD19) treatment for MM.76 Interestingly, the investigators saw no meaningful reductions in HLA antibodies after CAR-T (CD19) treatment.